More Stelara Biosimilars Line Up For Launch In US And EU

Samsung Bioepis And Sandoz Win US Ustekinumab Approval As Celltrion Endorsed By EMA

 
• By Dave Wallace

Samsung Bioepis and partner Sandoz have won approval for a third US Stelara biosimilar. Meanwhile, in Europe Celltrion has become the latest firm to qualify for an ustekinumab marketing authorization.

EU and US flags
More Stelara biosimilars have been endorsed by EU and US regulators • Source: Shutterstock

More from Biosimilars

More from Products